Get started
Author

Zamzam Salam Al-Hashami

Observed names: Al-Hashami, Zamzam, Z Al-Hashami, Z. Al Hashami, Z. Al-Hashami, Z.S. Al-Hashami, Zamzam Al Hashami, Zamzam Al-Hashami, Zamzam Al‐Hashami, Zamzam S. Al-Hashami
Observed institutions: BC Cancer Agency, Dalhousie University, University of British Columbia, Sultan Qaboos University Hospital, Sultan Qaboos Comprehensive Cancer Care & Research Center, Ninevah University, Sultan Qaboos University
ORCID: 0000-0001-6300-7013
Observed ORCID: 0000-0001-6300-7013
OpenAlex ID: A5005881789
Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world
2021 · Aria Shokoohi, Zamzam Al‐Hashami, et al. · Cancer Medicine · 34
PDF
Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer
2022 · Rebekah Rittberg, Bonnie Leung, et al. · Frontiers in Oncology · 16
PDF
Discordance in PD-L1 scores on repeat testing of non-small cell lung carcinomas
2021 · Julia R. Naso, Norbert Banyi, et al. · Cancer Treatment and Research Communications · 14
PDF
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy
2023 · Rebekah Rittberg, Bonnie Leung, et al. · Current Oncology · 10
PDF
Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing
2022 · Lauren Jones, Rebekah Rittberg, et al. · Current Oncology · 9
PDF
When cancer reaches the heart: a case series on rare myocardial and endocardial metastases from squamous cell carcinoma
2025 · Ahmed Basuoni, Ikram Burney, et al. · Archive of Clinical Cases · 7
PDF
Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers
2021 · Irene S. Yu, Zamzam Al-Hashami, et al. · Clinical Colorectal Cancer · 6
Hepatocellular Carcinoma in Oman: An analysis of 284 cases
2020 · Khalid Al-Naamani, Zamzam Al-Hashami, et al. · Sultan Qaboos University medical journal · 6
PDF
Pulmonary Toxicities of Immune Check Point Inhibitors in the Management of Cancer: Mini Review
2022 · B Jayakrishnan, Mansour Al-Moundhri, et al. · Advances in respiratory medicine · 5
PDF
Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: younger versus older adults
2023 · Bonnie Leung, Aria Shokoohi, et al. · BMC Cancer · 4
PDF
Adenocarcinoma of lung presenting as diffuse interstitial lung disease
2023 · B Jayakrishnan, Ikram Burney, et al. · The Lancet Oncology · 3
Lung cancer screening in the gulf
2022 · Sami M. Bennji, B. Jayakrishnan, et al. · Annals of Thoracic Medicine · 3
Silent Invader: Cardiac Metastasis From Buccal Squamous Cell Carcinoma
2024 · Abier Atabani, Ahmed Basuoni, et al. · Cureus · 2
Challenges in managing extensive brown tumors and renal stones in a young man with parathyroid carcinoma and single kidney: Case report
2024 · Syeda Sara Tajammul, Syed Furqan Hashmi, et al. · Current Problems in Cancer Case Reports · 1
The Prevalence and Patterns of Toxicity With Immune Checkpoint Inhibitors in Solid Tumors: A Real-World Experience From a Tertiary Care Center in Oman
2023 · Bushra Salman, Nameer M AlWard, et al. · Cureus · 1
PDF
Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care Utilization
2022 · Rebekah Rittberg, Bonnie Leung, et al. · Current Oncology · 1
PDF
Uptake of second-line anticancer therapy after first-line pembrolizumab in patients with stage IV non–small cell lung cancer with PD-L1 > 50%: Comparison between clinical trials and the real world.
2022 · Rebekah Rittberg, Lauren Jones, et al. · Journal of Clinical Oncology · 1
EP08.02-089 Toxicity of Sequential Tyrosine Kinase Inhibitors After Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer
2022 · L. Jones, R. Rittberg, et al. · Journal of Thoracic Oncology · 1
PDF
EP08.01-074 'Long Responders' Compared to 'Non-Responders' to a First Line Immune Checkpoint Inhibitor in Incurable Non-Small Cell Lung Cancer
2022 · R. Rittberg, B. Leung, et al. · Journal of Thoracic Oncology · 1
The impact of psychosocial distress on survival in patients diagnosed with gastrointestinal (GI) malignancies.
2019 · Zamzam Salam Al-Hashami, Cheryl Ho, et al. · Journal of Clinical Oncology · 1
Management of a Migrating Feeding Tube
2014 · Zamzam S. Al-Hashami, Khalid Al-Naamani, et al. · Sultan Qaboos University medical journal · 1
PDF
Complex cardiac overlap: immune checkpoint inhibitor myocarditis in hypertrophic obstructive cardiomyopathy with subsequent NSTEMI
2026 · Ahmed Basuoni, Marwa Makhlouf, et al. · Cardio-Oncology
The clinical utility of endobronchial ultrasound-guided transbronchial needle aspiration: A single-center experience from the Middle East
2026 · Sami M. Bennji, B. Jayakrishnan, et al. · Annals of Thoracic Medicine
When Constriction Is Not Just the Pericardium: Extrinsic Cardiac Encasement by Thymic Squamous Cell Carcinoma
2026 · Waleed Dawelbeit, Z Al-Hashami, et al. · Cureus
PDF
Effect of plasma-based molecular testing in patients with newly diagnosed advanced NSCLC on initiation of targeted agents in patients with targetable genomic alterations: A real world experience from the Middle East.
2024 · Anjana Joel, Zamzam Al-Hashami, et al. · Journal of Clinical Oncology
PDF
Works count: 35
Citation count: 127
H-index: 6
I10-index: 4
Year
Topic
Type